Empowered Funds Takes New $4.95M Stake in Chemical Maker Stepan
Empowered Funds LLC increased its stake in specialty chemical maker Stepan by $4.95 million after the company surpassed Q2 revenue and EPS expectations.
Stepan Company produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company is headquartered in Northfield, Illinois.
99 articles
Empowered Funds LLC increased its stake in specialty chemical maker Stepan by $4.95 million after the company surpassed Q2 revenue and EPS expectations.
Stepan Company reported mixed Q2 2026 financial results with stronger earnings but a six-month net loss while maintaining dividends, prompting investor analysis on converting specialty chemical assets
Various ETFs include Stepan Co stock in their portfolios, detailing fund metrics like AUM and expense ratios. This information assists investors in identifying diversified investment options primarily
Stepan Company shares have recovered over the past year despite a five-year decline, trading near their fair price-to-sales value of 0.6x. Future performance hinges on converting revenue to cash flow
Stepan Company reported approximately 2,301 employees worldwide as of March 2026, marking a 3.8% decline since 2023. Active job postings decreased by 60.9%, while the average global salary stands at $
Empowered Funds LLC increased its stake in Stepan Company by 124.8% to $8.7 million following strong quarterly earnings that beat estimates with 15% revenue growth.
Stepan Company exceeded Q2 revenue and earnings estimates, though analysts forecast a loss by 2026 despite higher price targets. The company is projected to grow faster than the broader industry throu
Stepan Co CFO Ruben Dario Velasquez settled 1,358 RSUs at $64.675 per share on August 10, 2026, withholding 398 shares for taxes. The remaining 2,716 RSUs will vest ratably over three years without a
Wall Street Zen upgraded Stepan Company (NYSE:SCL) to a "Buy" rating following strong quarterly earnings that exceeded EPS and revenue expectations. The positive outlook drove shares up 1.8% to $65.14
Stepan Company reported strong Q2 2026 sales and net income while affirming its quarterly dividend. Analysts note significant undervaluation via DCF models despite mixed shareholder returns over three
Stepan Company exceeded Q2 revenue and EPS expectations, reporting $684 million and $1.00 respectively. Analysts forecast a 2026 loss but raised price targets, expecting Stepan to outpace industry rev
Stepan Company reported Q2 2026 sales of US$684.11 million and affirmed its quarterly dividend. Analysts highlight potential undervaluation against peers despite recent stock momentum.
The Public Employees Retirement System of Ohio reduced its stake in Stepan Company by 94.1% in Q1, while the firm reported strong earnings with 15% revenue growth.
Stepan Company reported strong Q2 results and affirmed its dividend, citing governance changes. While valuation models suggest the stock is undervalued, risks from net losses remain.
Stepan Company reaffirmed its dividend despite a net loss in the first half of 2026, aiming to clarify long-term strategy. Analysts project significant revenue growth by 2029, suggesting a potential 1
Stepan Co reported Q2 2026 revenue of $684.1 million with doubled net income, driven by higher prices and improved product mix in surfactants.
Stepan Company VP Matthew John Eaken filed a beneficial ownership statement disclosing 9,319 direct shares and 3,102 indirect shares via an ESOP II Trust. The filing also details his holdings in stock
Stepan Company exceeded Q2 2026 expectations with $1.18 EPS and $684.1M revenue, up 15% YoY. Growth was driven by strong organic sales volume and performance in its surfactants division.
Stepan Company reported second-quarter adjusted earnings per share of $1.18, significantly surpassing FactSet estimates of $0.61. This result highlights the company's robust financial performance duri
Stepan Co. beat Q2 earnings and revenue estimates, posting $1.18 per share versus $0.61 expected and $684.11 million in revenue. While shares gained year-to-date, future performance hinges on manageme
Stepan Company reported a 102% surge in Q2 2026 net income driven by volume growth and margin recovery in Surfactants and Polymers. Simultaneously, the firm plans to reduce its global salaried workfor
Stepan Company declared a quarterly cash dividend of $0.395 per share, payable in September 2026, marking its 58th consecutive year of increases. As a major manufacturer of specialty chemicals and sur
Stepan Company declared a quarterly cash dividend of $0.395 per share, marking its 58th consecutive year of increases. The specialty chemical manufacturer produces surfactants and polyurethane polyols
Stepan Company is scheduled to release second-quarter earnings while executing its Project Catalyst restructuring plan. Analysts expect improved profitability driven by cost reductions and a shift tow
Stepan Co (SCL) holds a valuation score of 8.90, ranking 16th in the Chemicals industry, with a P/E ratio of -92.70 while other key metrics remain undisclosed.
Stepan Company reports a $1.30 billion market cap with the United States driving the majority of revenue alongside France. The article details the firm's financial performance across geographic region
Stepan Co (SCL) disclosed its major institutional shareholders, including BlackRock and Vanguard, highlighting investment advisors as the largest category. The report details historical shareholding d
Argus Research raised its target price for chemical manufacturer Stepan Company (SCL) to $62.00. The stock currently trades at $58.57 across its three business segments.
Argus Research raised its price target for Stepan Company (SCL) to $60.00, noting the firm manufactures diverse chemicals and chemical-based products. The stock currently trades at $57.57 following th
Stepan Company reported mixed 2024 financial results with declining net sales but improved profitability driven by lower raw material costs and a richer product mix in its specialty chemicals segment.